These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15611295)

  • 41. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
    Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New understanding of the pathogenesis of CML: a prototype of early neoplasia.
    Clarkson BD; Strife A; Wisniewski D; Lambek C; Carpino N
    Leukemia; 1997 Sep; 11(9):1404-28. PubMed ID: 9305592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.
    Dash AB; Williams IR; Kutok JL; Tomasson MH; Anastasiadou E; Lindahl K; Li S; Van Etten RA; Borrow J; Housman D; Druker B; Gilliland DG
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7622-7. PubMed ID: 12032333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cells.
    Schuh AC; Sutherland DR; Horsfall W; Mills GB; Dube I; Baker MA; Siminovitch K; Bailey D; Keating A
    Leukemia; 1990 Sep; 4(9):631-6. PubMed ID: 2168506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia.
    Aumann K; Lassmann S; Schöpflin A; May AM; Wöhrle FU; Zeiser R; Waller CF; Hauschke D; Werner M; Brummer T
    Hum Pathol; 2011 May; 42(5):719-26. PubMed ID: 21292300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis model.
    Melkus M; Bennaceur-Griscelli A; Valogne Y; Flamant S; Chomel JC; Sorel N; Bonnet ML; Deininger MW; Mitjavila-Garcia MT; Turhan AG
    Exp Hematol; 2013 Apr; 41(4):335-45.e3. PubMed ID: 23287417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blast crisis in a murine model of chronic myelogenous leukemia.
    Daley GQ; Van Etten RA; Baltimore D
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11335-8. PubMed ID: 1763047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.
    Holm F; Hellqvist E; Mason CN; Ali SA; Delos-Santos N; Barrett CL; Chun HJ; Minden MD; Moore RA; Marra MA; Runza V; Frazer KA; Sadarangani A; Jamieson CH
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15444-9. PubMed ID: 26621726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
    Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW
    Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphotyrosine phosphatase activity prevents the detection of P210bcr/abl protein in mature cells in chronic myelogenous leukemia even by an immunoblotting technique.
    Shibata K; Nishimura J; Takahira H; Nawata H
    Leukemia; 1989 Sep; 3(9):615-9. PubMed ID: 2474729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Src homology-2 protein Shb modulates focal adhesion kinase signaling in a BCR-ABL myeloproliferative disorder causing accelerated progression of disease.
    Gustafsson K; Jamalpour M; Trinh C; Kharas MG; Welsh M
    J Hematol Oncol; 2014 Jun; 7():45. PubMed ID: 24952416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
    Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
    Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
    Salgia R; Uemura N; Okuda K; Li JL; Pisick E; Sattler M; de Jong R; Druker B; Heisterkamp N; Chen LB
    J Biol Chem; 1995 Dec; 270(49):29145-50. PubMed ID: 7493940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
    Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
    Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
    Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R
    Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function.
    Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X
    Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.
    Skorski T; Nieborowska-Skorska M; Wlodarski P; Perrotti D; Martinez R; Wasik MA; Calabretta B
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13137-42. PubMed ID: 8917557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells.
    Lamkin TJ; Chin V; Yen A
    Am J Hematol; 2006 Aug; 81(8):603-15. PubMed ID: 16823827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.